MetLife Investment Management, LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 143 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$47,238
-55.4%
17,692
-27.6%
0.00%
-100.0%
Q4 2021$105,851
+110.5%
24,446
+147.4%
0.00%
Q3 2021$50,289
-69.6%
9,880
-62.2%
0.00%
-100.0%
Q2 2021$165,264
+306.3%
26,108
+396.2%
0.00%
Q1 2021$40,675
-58.7%
5,262
-65.0%
0.00%
-100.0%
Q4 2020$98,420
-1.5%
15,0260.0%0.00%0.0%
Q3 2020$99,923
-56.1%
15,026
-45.0%
0.00%
-66.7%
Q2 2020$227,426
+8.6%
27,3020.0%0.00%0.0%
Q1 2020$209,406
-7.7%
27,3020.0%0.00%
+50.0%
Q4 2019$226,880
+12.6%
27,3020.0%0.00%0.0%
Q3 2019$201,489
-34.2%
27,3020.0%0.00%
-33.3%
Q2 2019$306,327
+55.8%
27,302
+49.3%
0.00%
+50.0%
Q1 2019$196,618
-28.8%
18,2900.0%0.00%
-33.3%
Q4 2018$276,179
-18.4%
18,2900.0%0.00%
-25.0%
Q3 2018$338,365
-19.1%
18,2900.0%0.00%
-20.0%
Q2 2018$418,000
+9.1%
18,290
+35.9%
0.01%0.0%
Q1 2018$383,000
+56.3%
13,459
+16.0%
0.01%
+66.7%
Q4 2017$245,00011,5990.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
BVF INC/IL 5,803,700$25,130,0000.91%
Altium Capital Management LP 663,800$2,874,0000.79%
Rubric Capital Management LP 2,406,449$10,420,0000.49%
RTW INVESTMENTS, LP 6,029,700$26,109,0000.38%
Orbimed Advisors 3,214,509$13,919,0000.18%
TANG CAPITAL MANAGEMENT LLC 152,345$660,0000.13%
PLATINUM INVESTMENT MANAGEMENT LTD 980,085$4,244,0000.12%
Point72 Asset Management, L.P. 6,303,025$27,292,0000.11%
Sender Co & Partners, Inc. 40,720$176,0000.09%
Manteio Capital LLC 15,067$65,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders